Skip to content

Observation on clinical effect of acupoint catenary embedding in treatment of decreased ovarian function

Observation on clinical effect of acupoint catenary embedding in treatment of decreased ovarian function

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094373
Enrollment
Unknown
Registered
2024-12-20
Start date
2024-12-25
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished ovarian reserve

Interventions

Acupuncture control group:Ordinary acupuncture treatment is done 3 times a week, 3 menstrual cycles are treated, and the menstrual period is postponed to the menstrual net.
Acupoint catenary treatment group:Acupoint embedding is done once every 2 weeks, the treatment of 3 menstrual cycles, and the menstrual period is postponed to the net.

Sponsors

Chongqing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-40 years old; 2. The number of antral follicles AFC10U/L(more than 1 month interval between the two tests), estradiol E2 < 70pmol/L, anti-Mullerian hormone (AMH) <1.1 ng/mL. LH is normal or elevated. 3. Ovarian insensitivity syndrome and gonadal hypoplasia were excluded.

Exclusion criteria

Exclusion criteria: 1.Allergic to collagen line ; 2.acupoint local skin abnormalities ; 3. liver and kidney function, coagulation function serious abnormalities.

Design outcomes

Primary

MeasureTime frame
Follicle-stimulating hormone;Anti-mullerian hormone;Number of sinus follicles;

Secondary

MeasureTime frame
Luteinizing hormone;estradiol;

Countries

China

Contacts

Public ContactBaiShutong

Chongqing Hospital of Traditional Chinese Medicine

dengying111929@163.com+86 185 8051 8688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026